- Home
- CELC vs EVN Comparison
CELC vs EVN Comparison
Compare CELC & EVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- EVN
- Stock Information
- Founded
- CELC 2011
- EVN 1998
- Country
- CELC United States
- EVN United States
- Employees
- CELC N/A
- EVN N/A
- Industry
- CELC Medical Specialities
- EVN Investment Bankers/Brokers/Service
- Sector
- CELC Health Care
- EVN Finance
- Exchange
- CELC Nasdaq
- EVN Nasdaq
- Market Cap
- CELC 440.0M
- EVN 433.2M
- IPO Year
- CELC 2017
- EVN N/A
- Fundamental
- Price
- CELC $57.43
- EVN $11.01
- Analyst Decision
- CELC Strong Buy
- EVN
- Analyst Count
- CELC 5
- EVN 0
- Target Price
- CELC $53.60
- EVN N/A
- AVG Volume (30 Days)
- CELC 906.9K
- EVN 101.2K
- Earning Date
- CELC 08-14-2025
- EVN 01-01-0001
- Dividend Yield
- CELC N/A
- EVN 4.78%
- EPS Growth
- CELC N/A
- EVN N/A
- EPS
- CELC N/A
- EVN 0.34
- Revenue
- CELC N/A
- EVN N/A
- Revenue This Year
- CELC N/A
- EVN N/A
- Revenue Next Year
- CELC N/A
- EVN N/A
- P/E Ratio
- CELC N/A
- EVN $29.94
- Revenue Growth
- CELC N/A
- EVN N/A
- 52 Week Low
- CELC $7.58
- EVN $8.64
- 52 Week High
- CELC $63.06
- EVN $10.45
- Technical
- Relative Strength Index (RSI)
- CELC 64.38
- EVN 74.91
- Support Level
- CELC $50.44
- EVN $10.39
- Resistance Level
- CELC $63.06
- EVN $10.48
- Average True Range (ATR)
- CELC 3.17
- EVN 0.10
- MACD
- CELC -0.47
- EVN 0.06
- Stochastic Oscillator
- CELC 60.71
- EVN 100.00
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.